SK

Sushmita Kumari

Active Director Director DIN 08871816
DIN 08871816 First appointment Sep 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Sushmita Kumari

Data last updated:

Sushmita Kumari is a Director at Zelenia Pharma Private Limited (since 2020). The company operates in Trading. Zelenia Pharma Private Limited reported revenue of ₹53,002 (FY 2022).

DIN 08871816
Primary Designation Director
Industry Trading
First Appointment 10 Sep 2020
Oldest Company Age 6 yrs
Largest company Zelenia Pharma Private Limited · ₹53,002 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zelenia Pharma Private Limited U51909BR2020PTC047976
Director10 Sep 20202020₹53,002 (FY 2022)Active

Board colleagues of Sushmita Kumari

NameDINCompanyDesignation
Soni Kumari08871815Zelenia Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zelenia Pharma Private Limited
Premium access

Shareholding and investment profile for Sushmita Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushmita Kumari

Sushmita Kumari currently holds 1 directorship: Zelenia Pharma Private Limited (Director, since 10 Sep 2020, revenue ₹53,002 (FY 2022)).

Sushmita Kumari was first appointed on 10 Sep 2020 as Director at Zelenia Pharma Private Limited.

The current boards of Sushmita Kumari's companies include Soni Kumari (Zelenia Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available